Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kaur, Sandeep ^a   Harjai, Kusum ^a   Chhibber, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; HYDROXYPROPYLMETHYLCELLULOSE; LINEZOLID;

ANTIBIOTIC RESISTANCE; ARTHROPLASTY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ADHERENCE; COLONY FORMING UNIT; CONTROL STRATEGY; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFICACY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; IN VITRO STUDY; INFECTION PREVENTION; KIRSCHNER WIRE; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANALYSIS OF VARIANCE; ARTHROPLASTY; BACTERIOPHAGES; BONE WIRES; COMBINED MODALITY THERAPY; FLUORESCENCE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; METHYLCELLULOSE; MICROSCOPY, ELECTRON, SCANNING; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS;

EID: 84896913287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090411     Document Type: Article

References (61)

1. Widmer AF (2001) New developments in diagnosis and treatment of infection in orthopaedic implants. Clinical Infectious Diseases 33 (Suppl 2):94-106.
2. Goodman SB, Yao Z, Keeney M, Yang F (2013) The future of biologic coatings for orthopaedic implants. Biomaterials 34(13):3174-83.
3. McMillan DJ, Lutton C, Rosenzweig N, Sriprakash KS, Goss B, et al. (2011) Prevention of Staphylococcus aureus biofilm formation on metallic surgical implants via controlled release of gentamicin. Journal of Biomedical Science and Engineering 4:535-542.
4. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. The Lancet 358: 135-138. (Pubitemid 32709857)
5. Donlan RM (2002) Biofilms: microbial life on surfaces. Emerging Infectious Diseases 8:881-890.
6. Trampuz A, Widmer AF (2006) Infections associated with orthopaedic implants. Current Opinion in Infectious Diseases 19: 349-356.
7. Salgado CD, Dash S, Cantey JR, Marculescu CE (2007) Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clinical Orthopaedic Related Research 461: 48-53. (Pubitemid 47344093)
8. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clinical Orthopaedic Related Research 466: 1710-1715.
9. Walls RJ, Roche SJ, O'Rourke A, McCabe JP (2008) Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. Journal of Bone and Joint Surgery British Volume. 90: 292-298. (Pubitemid 351428942)
10. Raschke MJ, Schmidmaier G (2004) Biological coating of implants in trauma and orthopedic surgery. Unfallchirurg 107: 653-663, 2004. (Pubitemid 39237166)
11. Calhoun JH, Mader JT (1997) Treatment of osteomyelitis with a biodegradable antibiotic implant. Clinical Orthopaedic and Related Research 341:206-214. (Pubitemid 27333140)
12. Ambrose CG, Clyburn TA, Louden K, Joseph J, Wright J, et al. (2004) Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clinical Orthopaedic and Related Research 421:293-299. (Pubitemid 38579754)
13. Billon A, Chabaud L, Gouyette A, Bouler JM, Merle C (2005) Vancomycin biodegradable poly(lactideco-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release. Journal of Microencapsulation 22:841-852. (Pubitemid 43158186)
14. Kalicke T, Schierholz J, Schlegel U, Frangen TM, Koller M, et al. (2006) Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. Journal of Orthopaedic Research 24:1622-1640. (Pubitemid 44203294)
15. Sakoulas G, Moellering RC Jr (2008) Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clinical Infectious Diseases 46:S360-7. (Pubitemid 351717323)
16. Tenover FC, Moellering RC Jr (2007) The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clinical Infectious Diseases 44:1208-15. (Pubitemid 46651246)
17. Dhand A, Sakoulas G (2012) Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy. F1000 Medicine Reports 4: 4.
18. Costerton JW, Montanaro L, Arciola CR (2005) Biofilm in implant infections: its production and regulation. International Journal of Artificial Organs 28:1062-1068. (Pubitemid 43085399)
19. Neut D, van de Belt H, Stokroos I, van Horn JR, van der Mei HC, et al. (2001) Biomaterial associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. Journal of Antimicrobial Chemotherapy 47:885-891. (Pubitemid 32519840)
20. Hickok NJ, Shapiro IM (2012) Immobilized antibiotics to prevent orthopaedic implant infections. Advanced Drug Delivery Reviews 64(12): 1165-1176.
21. Wan AT, Conyers RAJ, Coombs CJ, Masterton JP (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clinical Chemistry 37:1683-7. (Pubitemid 21892727)
22. Tweden K, Cameron JD, Razzouk A, Holmberg W, Kelly S (1997) Biocompatibility of silver-modified polyesters for antimicrobial protection of prosthetic valves. Journal of Heart Valve Disease 6: 553-6.
23. Sulakvelidze A, Morris JG (2001) Bacteriophages as therapeutic agents. Annals of Medicine 33: 507-509, (Pubitemid 33052270)
24. Sulakvelidze A, Alavidze Z, Morris J (2001) Bacteriophage therapy. Antimicrobial Agents and Chemotherapy 45: 649-659. (Pubitemid 32182003)
25. Duckworth D, Gulig P (2002) Bacteriophage: potential treatment for bacterial infections. Biodrugs 16:57-62. (Pubitemid 34303968)
26. Azeredo J, Sutherland IW (2008) The use of phages for the removal of infectious biofilms. Current Pharmaceutical Biotechnology 9:261-6.
27. Kutateladze M, Adamia R (2010) Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnology; 28:591-5.
28. Abedon ST, Thomas-Abedon C (2010) Phage therapy pharmacology. Current Pharmaceutical Biotechnology 2010; 11:28-47.
29. Skurnik M, Strauch E (2007) Phage therapy: facts and fiction. International Journal of Medical Microbiology 296: 5-14. (Pubitemid 43089713)
30. Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1:111-114.
31. Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, et al. (2002) Linezolid penetration into osteo-articular tissues. Journal of Antimicrobial Chemotherapy 50: 747-50. (Pubitemid 35331696)
32. Lovering AM, Zhang J, Bannister GC (2002) Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. Journal of Antimicrobial Chemotherapy 50: 73-7. (Pubitemid 34785257)
33. Kutscha-Lissberg F, Hebler U, Muhr G, Koller M (2003) Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy 47: 3964-6. (Pubitemid 37485016)
34. Grohs P, Kitzis MD, Gutmann L (2003) In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 47:418-420. (Pubitemid 36070400)
35. Bernardo K, Pakulat N, Fleer S, Schnaith A, Utermohlen O, et al. (2004) Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrobial Agents and Chemotherapy 48:546-55. (Pubitemid 38141715)
36. Gemmell CG, Ford CW (2002) Virulence factor expression by Gram-positive cocci exposed to sub-inhibitory concentrations of linezolid. Journal of Antimicrobial Chemotherapy 50:665-672. (Pubitemid 35331683)
37. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, et al. (2007) Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 195: 202-211. (Pubitemid 46080052)
38. Wayne PA (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. Clinical and Laboratory Standards Institute.
39. Kaur S, Chhibber S, Harjai K (2012) Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sub-lethal concentrations of antibiotics. Applied and Environmental Microbiology 78: 8227-8233.
40. Kumari S, Harjai K, Chhibber S (2011) Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. Journal of Medical Microbiology 60: 205-210.
41. Langley R, Kenna DT, Vandamme P, Ure R, et al. (2003) Lysogeny and bacteriophage host range within the Burkholderia cepacia complex. Journal of Medicine Microbiology 52:483-490. (Pubitemid 36774235)
42. Alfadhel M, Puapermpoonsiri U, Ford SJ, McInnes FJ, van der Walle CF (2011) Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. International Journal of Pharmaceutics 416 (1):280-287.
43. Gollwitzer H, Ibrahim K, Meyer H, Mittelmeier W, Busch R, et al. (2003) Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. Journal of Antimicrobial Chemotherapy 51: 585-591. (Pubitemid 36336150)
44. Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE (2005) Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. Journal of Antimicrobial Chemotherapy 55: 792-795. (Pubitemid 40691865)
45. Patel SA (2012) Visible spectrophotometric method for estimation of linezolid in tablet and injection dosage form. International Journal of Pharmaceutical Research. 4(3).
46. O'Neill AJ, Cove JH, Chopra I (2001) Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 47:647-650. (Pubitemid 32447653)
47. Cowsar DR (1974) Introduction to controlled release. Advances in Experimental Medicine and Biology 47:1-13.
48. Fines M, Leclercq R (2000) Activity of linezolid against gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. Journal of Antimicrobial Chemotherapy 45: 797-802. (Pubitemid 30348949)
49. Moellering RC (2003) Linezolid: the first oxazolidinone antimicrobial. Annals of International Medicine 138:135-142.
50. Herrmann DJ, Peppard WJ, Ledeboer NA, Theesfeld ML, Weigelt JA, et al. (2008) Linezolid for the treatment of drug-resistant infections. Expert Review of Anti-infective Therapy 6 : 825-48.
51. Carlton RM (1999) Phage therapy: past history and future prospects. Archivum Immunologiae et Therapia Experimentalis 5:267-74.
52. Verheust C, Pauwels K, Mahillon J, Helinski DR, Herman P (2010) Contained use of bacteriophages: risk assessment and biosafety recommendations. Applied Biosafety 15 (1):32-44.
53. Alderman DA (1984) A review of cellulose ethers in hydrophilic matrices for oral controlled release dosage form. International Journal of Pharmaceutical Technology and Product Manufacture 5:1-9.
54. Pham AT, Lee PI (1994) Probing the mechanisms of drug release from hydroxypropylmethyl cellulose matrices. Pharmaceutical Research 11:1379-1384. (Pubitemid 24339641)
55. Lee BJ, Ryu SG, Cui JH (1999) Controlled release of dual drug-loaded hydroxypropyl methyl cellulose matrix tablet using drug-containing polymeric coatings. International Journal of Pharmaceutics 188:71-80.
56. Ford JL, Rubinstein MH, McCaul F, Hogan JE, Edgar PJ (1987) Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methylcellulose matrix tablet. International Journal of Pharmacy 40:223-234. (Pubitemid 18025827)
57. Pradhan R, Budhathoki U, Thapa P (2008) Formulation of once a day controlled release tablet of indomethacin based on HPMC-Mannitol. Journal of Science and Engineering Technology 1(5):55.
58. Puapermpoonsiri U, Ford SJ, van der Walle CF (2010) Stabilization of bacteriophage during freeze drying. International Journal of Pharmacy 389: 168-175.
59. Bedi MS, Verma V, Chhibber S (2009) Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World Journal of Microbiology Biotechnology 25: 1145-1151.
60. Partridge SR (2011) Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS Microbiology Reviews 35:820-855.
61. Djurkovic S, Loeffler JM, Fischetti VA (2005) Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrobial Agents and Chemotherapy 49: 1225-1228. (Pubitemid 40327756)